# Comparing Efficacy and Safety of CinnaGen Beta Erythropoietin (CinnaPoietin®) Versus Eprex® on the Treatment of Anemia in ESRD Hemodialysis Patients

Study · id `cardio:ct-nct03408639` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03408639](<https://clinicaltrials.gov/study/NCT03408639>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03408639

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 156 participants.

## Technical summary

Registry record NCT03408639. Randomized; quadruple masking; primary purpose treatment. Start 2016-06-22 (actual); primary completion 2017-07-19 (actual). Results posted on 2019-11-06.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 156 participants (enrolled count; ClinicalTrials.gov record NCT03408639, source copy `cardio:ctgov-nct03408639-2019-12-18`, retrieved 2026-10-26)
- Started: 2016-06-22 (actual) (ClinicalTrials.gov record NCT03408639, source copy `cardio:ctgov-nct03408639-2019-12-18`, retrieved 2026-10-26)
- Primary completion: 2017-07-19 (actual) (ClinicalTrials.gov record NCT03408639, source copy `cardio:ctgov-nct03408639-2019-12-18`, retrieved 2026-10-26)
- Completion: 2017-07-19 (actual) (ClinicalTrials.gov record NCT03408639, source copy `cardio:ctgov-nct03408639-2019-12-18`, retrieved 2026-10-26)
- Results first posted: 2019-11-06 (ClinicalTrials.gov record NCT03408639, source copy `cardio:ctgov-nct03408639-2019-12-18`, retrieved 2026-10-26)
- Countries: Iran (ClinicalTrials.gov record NCT03408639, source copy `cardio:ctgov-nct03408639-2019-12-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03408639-2019-12-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparing Efficacy and Safety of CinnaGen Beta Erythropoietin (CinnaPoietin®) Versus Eprex® on the Treatment of Anemia in ESRD Hemodialysis Patients
- Condition: Anemia in End-Stage Renal Disease
- Intervention (Drug): CinnaPoietin®
- Intervention (Drug): Eprex®
- Intervention (Drug): Nephrovit
- Intervention (Drug): Vitamin B12 Injection
- Lead sponsor: Cinnagen
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Comparing Therapeutic Efficacy and Safety of Epoetin Beta and Epoetin Alfa in the Treatment of Anemia in End-Stage Renal Disease Hemodialysis Patients (`cardio:pubmed-30253403`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 74e0b96822d7d4c430555efe2e1d29e60124fc5d6db738c01be60a2fcc9c35ea
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
